Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-19 10:31 am Purchase | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 600,480 9.990% | 43,070 (+7.73%) | View |
| 2023-09-08 06:07 am Unchanged | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 557,410 9.900% | 0 (Unchanged) | View |
| 2023-08-24 08:20 am Purchase | 13G | COMERA LIFE SCIENCE HLDGS INC CMRA | Singer Nicholas Jason | 1,445,448 5.170% | 1,445,448 (New Position) | View |
| 2023-07-26 5:05 pm Purchase | 13D | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 557,410 9.990% | 557,410 (New Position) | View |
| 2022-12-20 4:30 pm Sale | 13D | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 393,766 7.670% | -1,701,234 (-81.20%) | View |
| 2022-02-16 5:15 pm Sale | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 2,095,000 4.000% | -1,696,983 (-44.75%) | View |
| 2021-04-30 4:05 pm Purchase | 13G | Eterna Therapeutics Inc. ERNA | Singer Nicholas Jason | 3,791,983 9.130% | 3,791,983 (New Position) | View |